|
|
|
|
|
Analysis of risk factors for sepsis-induced Takotsubo cardiomyopathy |
Ge Jian-hui, Ge Xiang-jun |
Department of Emergency Medicine, Ninghai First Hospital, Ninghai 315600, China |
|
|
Abstract Objective To analyze the risk factors for sepsis-induced Takotsubo cardiomyopathy (TTC). Methods A total of 241 cases with sepsis admitted to our hospital from March 2015 to March 2018 were analyzed. Clinical parameters at admission were collected: age, sex, body mass index, echocardiography results, and laboratory parameters such as inflammation index and myocardial enzyme spectrum. According to the selected TTC patients, sepsis patients with normal cardiac function were selected and divided into TTC group and non-TTC group. Variables with significant statistical significance in the univariate analysis were introduced with multivariate logistic regression analysis of sepsis-induced risk factors for TTC. Results There were 31 cases in TTC group and 210 cases in the non-TTC group. The males in the TTC group were significantly lower than those in the non-TTC group (35.5% vs. 56.7%, P=0.027), and the myocardial enzyme spectrum of cTnT, NT-proBNP, and CK-MB were significantly higher in the TTC group (P<0.05). In treatment regimens, the proportion of introotropic drugs used in the TTC group was significantly higher than that in the non-TTC group (45.2% vs. 26.7%, P=0.034). Echocardiographic results showed a significant reduction in left ventricular ejection fraction in the TTC group (39.5±10.4 vs. 59.3±5.7, P<0.001). The left ventricular end systolic diameter (LVIDs) (3.42±0.74 vs. 2.59±0.53, P<0.001) and left ventricular end-diastolic diameter (LVIDd) (4.62±0.52 vs. 4.31±0.51, P=0.002) increased compared with the non-TTC group. There was no statistical difference in diastolic function parameters such as E wave (P=0.160), A wave (P=0.093), E wave deceleration time (P=0.098) and E and e′(s) ratio (P=0.649). Multivariate analysis showed that troponin T(OR=1.965, 95%CI1.122-3.785, P<0.001) and inotrope (OR=1.445, 95%CI1.217-4.263,P<0.001) were independent risk factors for sepsis-induced TTC. Concluson Increased troponin levels and positive inotropic agents are risk factors for TTC after sepsis. Early detection and prevention of these high-risk patients is warranted.
|
|
About author:: Ge Jian-hui, E-mail: wading1012@163.com |
|
|
|
[1]Vallabhajosyula S, Jentzer JC, Geske JB, et al. New-onset heart failure and mortality in hospital survivors of sepsis-related left ventricular dysfunction[J]. Shock, 2017, 49(2): 144-149.
[2]Ranieri M, Finsterer J, Bedini G, et al. Takotsubo Syndrome: Clinical Features, Pathogenesis, Treatment, and Relationship with Cerebrovascular Diseases[J]. Curr Neurol Neurosci Rep, 2018, 18(5):20.
[3]Izumo M, Akashi YJ. Role of echocardiography for takotsubo cardiomyopathy: clinical and prognostic implications[J]. Cardiovasc Diagn Ther, 2018, 8(1):90-100.
[4]Ansari U, El-Battrawy I, Fastner C, et al. Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy[J]. BMC Cardiovasc Disord, 2018, 18(1):54.
[5]Tsolaki V, Makris D, Mantzarlis K, et al. Sepsis-Induced Cardiomyopathy: Oxidative Implications in the Initiation and Resolution of the Damage[J].Oxid Med Cell Longev. 2017, 2017:T 393 525.
[6]Ouerghi K, Boukhris M, Grall S, et al. Reverse iatrogenic Takotsubo syndrome after accidental bolus of norepinephrine in the setting ofsepsis[J]. Kardiol Pol, 2016, 74(8):799.
[7]Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8):801-810.
[8]Lyon AR, Bossone E, Schneider B, et al. Current state of knowledge on Takotsubo syndrome: a position statement from the taskforce on takotsubo syndrome of the heart failure association of the European society of cardiology[J]. Eur J Heart Fail, 2016, 18(1): 8-27.
[9]Park JH, Kang SJ, Song JK, et al. Left ventricular apical ballooning due to severe physical stress in patients admitted to the medical ICU[J].Chest, 2005, 128(1): 296-302.
[10]Lee PH, Song JK, Sun BJ, et al. Outcomes of patients with stressinduced cardiomyopathy diagnosed by echocardiography in a tertiary referral hospital[J]. J Am Soc Echocardiogr, 2010, 23(7):766-771.
[11]Brinjikji W, El-Sayed AM, Salka S.et al.In-hospital mortality among patients with takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009[J]. Am Heart J, 2012, 164(2):215-221.
[12]Isogai T, Yasunaga H, Matsui H, et al. Out-of-hospital versus inhospital takotsubo cardiomyopQathy: analysis of 3719 patients in the Diagnosis Procedure Combination database in Japan[J]. Int J Cardiol, 2014, 176(2):413-417.
[13]Gopalakrishnan P, Zaidi R, Sardar MR,et al.Takotsubo cardiomyopathy: Pathophysiology and role of cardiac biomarkers in differential diagnosis[J].World J Cardiol, 2017, 9(9):723-730.
[14]Lee JW, Kim JY, Youn YJ, et al. Clinical characteristics and prognostic factors of stress-induced cardiomyopathy[J].Korean Circ J, 2010, 40(6):277-282.
[15]Cappelletti S,Ciallella C,Aromatario M,et al.Takotsubo cardiomyopathy and sepsis [J].Angiology, 2017, 68(4):288-303.
[16]Casey RT,Challis BG,Pitfield D,et al.Management of an acute catecholamine-induced cardiomyopathy and circulatory collapse: a multidisciplinary approach[J].Endocrinol Diabetes Metab Case Rep, 2017,17:122.
[17]El-Battrawy I, Lang S, Ansari U, et al. Incidence and prognostic relevance of cardiopulmonary failure in takotsubo cardiomyopathy[J].Sci Rep, 2017, 7(1):14 673.
[18]Paur H, Wright PT, Sikkel MB, et al. High levels of circulating epinephrine trigger apical cardiodepression in a b2-adrenergic receptor/Gi-dependent manner: a new model of takotsubo cardiomyopathy[J]. Circulation, 2012, 126(6):697-706.
[19]Pathan N, Franklin JL, Eleftherohorinou H, et al. Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase[J]. Crit Care Med, 2011, 39(7):1692-1711.
[20]Santoro F, Tarantino N, Ferraretti A,et al.Serum interleukin 6 and 10 levels in Takotsubo cardiomyopathy: Increased admission levels may predict adverse events at follow-up[J].Atherosclerosis 2016,254:28-34.
[21]Y-Hassan S, Settergren M, Henareh L,et al.Sepsis-induced myocardial depression and takotsubo syndrome[J]. Acute Card Care, 2014, 16(3):102-109.
[22]Habes QLM, van Ede L, Gerretsen J, et al. Norepinephrine contributes to enterocyte damage in septic shock patients: a prospective cohort study[J].Shock, 2018, 49(2):137-143. |
|
|
|